retatrutide phase 2 results 2024 2025 Month 1 Results: Typical Weight Loss Retatrutide vs. Tirzepatide for Weight
Description
Taking more than the recommended dose does not increase weight loss and significantly raises the risk of gastrointestinal side effects
Talk to your health care provider about your thyroid cancer risk with GLP-1 drugs
Most patients begin noticing changes in appetite and eating habits within the first 2-4 weeks
This imposes pressures on healthcare systems, insurers, and patients, especially in markets with limited reimbursement coverage
These holistic support programs often combine lifestyle changes with the weight loss medications to improve adherence and set patients up for success
I suspect this is from the glucagon agonism of the drug as glucagon stimulates the formation of extra bile acids/bile salts in the liver which can be very irritating to the intestinal lining causing diarrhea
